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Inﬂuenza virusEnveloped viruses and cellular transport vesicles share obvious morphological and functional properties.
Both are composed of a closed membrane, which is lined with coat proteins and encases cargo.
Transmembrane proteins inserted into the membrane deﬁne the target membrane area with which the
vesicle or virus is destined to fuse. Here we discuss recent insight into the functioning of enveloped viruses in
the framework of the “functional module” concept. Vesicular transport is an exemplary case of a functional
module, as deﬁned as a part of the proteome that assembles to perform a speciﬁc autonomous function in a
living cell. Cellular vesicles serve to transport cargo between membranous organelles inside the cell, while
enveloped viruses can be seen as carriers of the viral genome delivering their cargo from an infected to an
uninfected cell. The turnover of both vesicles and viruses involves an analogous series of submodular events.
This comprises assembly of elements, budding from the donor compartment, uncoating and/or maturation,
docking to and ﬁnally fusion with the target membrane to release the cargo. This modular perception enables
us to deﬁne submodular building blocks so that mechanisms and elements can be directly compared. It will
be analyzed where viruses have developed their own speciﬁc strategy, where they share functional schemes
with vesicles, and also where they even have “hijacked” complete submodular schemes from the cell. Such a
perspective may also include new and more speciﬁc approaches to pharmacological interference with virus
function, which could avoid some of the most severe side effects.Biology, Vet.-Med. Faculty of
any. Tel.: +49 3020936272;
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction to functional modules
In this contribution we want to compare viruses and cellular
vesicles on the level of “functional modules”. This term arose from the
notion that major reaction pathways in the living cell are carried out
by speciﬁc subsets of the proteome. Time-ordered interaction and
complex formation within these ensembles of macromolecules
facilitate an autonomous function. Functional modules include the
important group of macromolecular machines organised as a compact
structure, such as the ribosome or the proteasome. However, there are
also ensembles that are more dynamic by changing their composition
and/or organisation during function. To include the latter group as
well, the term “functional module” is used. Common to all modules
are a characteristic time domain at which the respective functional
cycle proceeds and a certain sequestration from the rest of the cell by
spatial limitations, by chemical speciﬁcity, and/or by the time domain
at which function proceeds.
In terms of systems analysis [1], functional modules mean
ensembles of molecular elements that are integral parts of a network
but can be separated from its other parts. The separation is not only amethod to facilitate the quantitative analysis of interaction data. It is
rather supposed to reﬂect biological reality in the sense of the general
deﬁnition of module as “a self-contained unit of a system that
performs a speciﬁc task in support of its major function”. Speciﬁc
network motifs such as “hubs” or “cliques” can now be assigned to
stable or dynamic protein complexes [2]. An alternative to such a
“holistic” systems approach is a “bottom up” approach that starts from
known properties of the single macromolecules and their interactions
and attempts to reconstruct the behaviour of macromolecular
assemblies from the behaviour of their elements. This approach is
based on the methods and concepts of molecular biology, biochem-
istry and biophysics. It is naturally limited to small ensembles but has
the potential to elucidate how the system's performance arises from
the combination of its microscopic molecular properties. This
becomes most important when the biological function of the module
depends crucially on a speciﬁc molecular detail and/or a speciﬁc time
window. Examples include the γ-secretase module, in which speciﬁc
key amino acids determine the kinetics and extent of monomer
assembly and eventually the toxicity of the whole polymer [3].
Another example are signal transduction modules, where the
functional cycle comprises sequential interactions, which are – often
with GTPases as timers – only activated in certain time windows. Also
mechano-chemical GTPases of the dynamin superfamily employ
nucleotide binding and hydrolysis to set a sophisticated time window
in which their self-assembly, their membrane remodelling activity
Fig. 1. Cellular coated vesicles and enveloped viruses: basic composition. Both vesicles
and viruses contain a membrane bilayer (thin black circle) derived from the donor
membrane, which is lined by a coat (red circle) assembled from soluble, monomeric
subunits. Inserted into the bilayer are transmembrane proteins (blue) required for
targeting of the vesicle or virus. The interior contains cargo (grey ellipse), either protein
or the viral genome. Insets: EM-pictures of COP I vesicles (left, by courtesy of Christoph
Rutz and Britta Brügger, Biochemiezentrum, Heidelberg) and of inﬂuenza viruses (right,
recreated 1918 inﬂuenza virus particles, taken from the Centers for Disease Control and
Prevention's Public Health Image Library, identiﬁcation number #8160). Note that the
scheme is a drastic simpliﬁcation to compare analogue structures in viruses and
vesicles. Especially the term “coat” often comprises a multitude of different proteins,
which might also have additional functions.
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communication).
Generally, functional modules may show either a stable organisa-
tion or dynamic assembly and disassembly during function. The ﬁrst
case includes the macromolecular machines with compact structure,
such as the ribosome or the proteasome, while the latter case includes
signal transducers and intracellular transport vesicles. Oriented on the
machines, we assume that modules go through functional cycles. On
receiving an input, only one (or a few) elements are initially activated.
Subsequently the elements involved increase in their number and
may form transient structures of higher hierarchy, each performing a
well-deﬁned subtask. This is the submodular level, which performs
regulatory functions such as checking the input, signal ampliﬁcation
or negative feedback, which cannot be performed by single elements.
On the modular level the submodular contributions are integrated
and the output is generated. Towards the end of the functional cycle
more andmore elements are deactivated until eventually all elements
of the module are back in place again [4].
Vesicular transport of proteins and other molecules in eukaryotic
cells ﬁts well the functional module scheme. The different steps are
accomplished by submodular entities, which work together in a
coordinated process. These include the sorting of cargo, the budding
and scission of the vesicle from the donor membrane, the uncoating,
and ﬁnally the tethering, docking and membrane fusion at the
acceptor compartment [4,5]. Each transport step, e.g. between the
endoplasmic reticulum and the Golgi or between the Golgi and the
plasma membrane, depends on its own speciﬁc protein repertoire
[6,7]. This does not exclude that, as will be discussed below, certain
elements such as the Bet3 and p115 proteins can be associated with
more than one submodular (or even modular) function [8]. One
concept to explain the occurrence of multifunctional proteins might
be called “protein parsimony”. In this view, there are simply not
enough protein species (only 25,000 genes in humans) to serve all the
different functions in a complicated eukaryotic cell under a variety of
physiological states. Protein parsimony is especially important for
replication of viruses, which is a race against time until the immune
system of the host has acquired the ability to stop further spread and
transmission of the virus. Thus, there is constant selection pressure for
viruses to speed up their replication. One factor to achieve this goal
are multifunctional proteins (and thus fewer genes), which allow
faster ampliﬁcation of the viral genome.
The functional cycle of transport vesicles starts with the uptake of
cargo that carries an appropriate transport signal and ends when the
same cargo is delivered to its acceptor compartment. A functional
cycle of the transport module is closed when the cargo has been
delivered and the molecules executing the function have been
recycled to their starting positions. Analogously, we deﬁne the
inclusion of the viral genome into virus particles preassembled at
membranes of infected cells as the input into the viral module and the
release of the genome into the cytoplasm of an uninfected cell as the
modular output. In spite of their quite different donor and acceptor
compartments, the individual steps of vesicle transport and virus
replication can be divided into clearly deﬁned and functionally
conserved submodules and follow basically the same series of events:
1. assembly of elements, 2. vesicle budding from the donor
membrane, 3. uncoating or maturation, 4. tethering and docking of
the vesicle or virus to the acceptor compartment and ﬁnally 5.
membrane fusion and cargo release. The general buildup of vesicles
and viruses is schematically depicted in Fig. 1 and described further
below, the processes of the respective functional module are shown in
Fig. 2 and covered in-depth through the remainder of the article.
Using the concept of functional modules, we will depict the notion
that enveloped viruses can be regarded as “vesicular carriers of the
viral genome” which transport their cargo, the viral genome and (in
the case of negative-stranded RNA and retroviruses) accessory
proteins required for its replication, by budding from the donormembrane in the infected cell and fusing with an acceptor membrane
in the target cell to be infected. In the following, we will focus on
small, enveloped viruses, mainly on inﬂuenza virus, but also mention
other well-characterized pathogens such as the retrovirus human
immunodeﬁciency virus (HIV; see glossary for a list of abbreviations)
or model viruses such as the alphavirus Semliki Forest Virus (SFV) and
the vesicular stomatitis virus (VSV). It is our hope that the comparison
with vesicular transport will provide insight into molecular mechan-
isms at the border between cell biology and virology.
2. Similarities and differences between vesicles and
enveloped viruses
Morphology is the most obvious level on which enveloped viruses
and cellular transport vesicles resemble each other (Fig. 1). Both
contain a membrane bilayer with a lipid composition identical (or
very similar) to that of the membrane from which the vesicle or virus
is derived. Transmembrane proteins are inserted into the bilayer and
mediate attachment of the vesicle or virus to and fusion with the
acceptor membrane. The bilayer is lined, either on the inside or on the
outside, with coat proteins. Cellular vesicles involved in intra-Golgi
transport contain a COP I coat, those that promote transport from the
ER to the Golgi a COP II coat and for transport from the trans-Golgi-
network to the endosome as well as for trafﬁcking within the
endocytic pathway a clathrin-coat is required. In the case of viruses
the term “coat” comprises a variety of proteins, whichmight also have
other functions. In the simple alphaviruses, such as SFV, the coat is an
icosahedral capsid, which has also the function to encase the genome.
In HIV, both functions are encoded by the gag-gene, whose product is
proteolytically cleaved during virus budding to yield the coat and the
capsid. Para- and orthomyxoviruses as well as VSV contain separate
genes for the matrix protein, that builds the coat, and for the capsid
protein. The large herpes viruses contain an amorphous structure
beneath the envelope, called the tegument, which contains a
multitude of proteins with a wide variety of functions. These coat
proteins often drive the formation of the vesicle or virus by assembly
and oligomerization at the budding site, and/or they deﬁne the shape
of the particle. The interior of the particle contains the cargo, either
cellular proteins or the viral genome encased in an icosahedral or
helical capsid. Furthermore, cellular transport vesicles and enveloped
viruses have almost the same size (50–100 nm and 40–300 nm,
respectively), indicating that the curvature of their membranes is
similar. A summary of the functional elements of the vesicle module
and two representative viruses, inﬂuenza virus and HIV, is given in
Table 1.
Since the high protein concentration in the cell's cytosol severely
restricts diffusion of large size particles, such as vesicles or viruses (or
submodular structures, such as capsids), an active mechanism is
required for their transport over long distances. For that purpose both
vesicles and viruses rely on interactions with the cytoskeleton. In
Fig. 2. Functional input/output cycles. The ﬁgure illustrates the notion of enveloped viruses as “vesicular carriers of the viral genome”. The input into both vesicular and viral
transport modules is the uptake of cargo, either protein or the viral genome, from a donor compartment, the output is the release of cargo into another membrane-encased acceptor
compartment. The individual steps of vesicle transport and virus replication are shown to follow a similar sequence of submodular events, comprising assembly of elements, budding
from the donor membrane, uncoating of vesicles or maturation of viruses, tethering and docking of the vesicle or virus to the acceptor compartment, membrane fusion, and cargo
release and uncoating. Note that some viruses bud into the lumen of membranous organelles of the exocytic pathway (ER/Golgi) and are subsequently secreted by the cell. Likewise,
some viruses enter the cell via the endocytic pathway and fuse with the membrane of early and late endosome or with vesicles that transport cargo between them. Maturation of
viruses often occurs also inside the cell, e.g. in the exocytic pathway or after endocytic uptake. Furthermore, for herpes viruses the term “maturation” refers to the acquisition of
tegument and envelope by the nucleocapsid, which originates from budding of capsid through the inner nuclear membrane and their subsequent fusion with the outer nuclear
membrane. See text for details.
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system facilitates transport underneath the plasma membrane and
probably inside the nucleus. Transport from the cell's periphery to the
nucleus (or more precisely to the perinuclear microtubuli organising
center) and vice versa is achieved by the motor proteins dynein and
kinesin, respectively, which move particles along microtubules.
Viruses do not only misuse the cytoskeleton of the cell for their own
purpose, but also hijack its vesicular transport system. During virus
entry the endocytic pathway is used for virus transport towards the
nucleus, whereas the exocytic pathway is utilized to deliver spike
proteins to the plasmamembrane or to secrete virus particles that bud
into the lumen of exocytic organelles, such as the ER or the Golgi
[9,10].
There are, of course, also obvious differences between cellular
modules and virus particles. First of all, vesicles and viruses perform
their tasks in different environments, i.e. transport of cargo within a
cell or between cells, respectively. Therefore, vesicles bud into the
cell's cytosol, whereas enveloped viruses bud out of the cytosol into
the extracellular space or into a topologically equivalent compart-
ment, such as the lumen of the endoplasmic reticulum (ER) or of the
Golgi apparatus.
The different topology of budding has certain consequences: since
budding of both vesicles and viruses requires assembly of coatTable 1
Comparison of the structural elements of cellular transport vesicles with two enveloped vir
Cellular vesicles Inﬂue
Transmembrane proteins v-SNARE (different variants for each
transport step)
Hema
neuraTask: attachment to and fusion with
acceptor membrane
Coat proteins Clathrin or COP I or COP II Matrix
Task: polymerization, budding,
morphology
Cargo Proteins: membrane or lumenal Genom
eightTask: signalling to initiate budding
Membrane bilayer Derived from different donor membranes,
various composition
Derive
membTask: recruitment of coat, envelope
formationproteins synthesized in the cytosol, the resulting cellular transport
vesicles have their coat on the outside whereas virus particles possess
a coat lining the inside of its membrane. As a further consequence
cellular transport vesicles must uncoat prior to fusion to expose the
elements required for the recognition of the acceptor compartment. In
contrast, uncoating of virus particles can occur only during or after
fusion of viral and cellular membranes (Fig. 2).
Another difference between vesicles and viruses arises from the
environment in which they perform their function. Budded virus
particles are metabolically inactive, crystalline entities in search of
suitable target cells. During transport within or between organisms
they encounter changing, sometimes harmful environmental condi-
tions, and the main function of the viral module is to protect the virus
genome against those inﬂuences. In contrast, cellular transport
vesicles operate within the same environment, the cell's cytosol,
which also provides energy and metabolites. As a consequence,
vesicles are functionally active after budding, e.g. they hydrolyze GTP
and uncoat, which is an obligatory series of eventsmandatory for their
task of protein transport.
Furthermore, after cargo has been delivered to the acceptor
membrane, the elements of vesicular carriers are recycled to their
start position, which allows further cycles of cargo transport with
the same elements. In contrast, elements of the viral moduleuses, inﬂuenza and human immunodeﬁciency virus.
nza virus Human immunodeﬁciency virus (HIV)
gglutinin (HA, attachment and fusion),
minidase (NA, detachment after budding)
gp160 with subunits gp120
(attachment) and gp41 (fusion)
protein (M1) gag (four subunits)
e plus associated proteins: arranged in
different ribonucleoparticles (vRNP)
Genome plus associated proteins:
arranged in one segment
d from subdomains of the plasma
rane, enriched in raft-lipids
Derived from subdomains of the plasma
membrane, enriched in raft-lipids
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re-use of an element after performing its function) does not occur.
Even more, elements of the viral module are ampliﬁed after delivery
of the cargo using the machinery of the freshly infected host cells.
Although negative feedback loops occur at the submodular level,
they are absent for the whole replication cycle of viruses. This
ensures that a maximal number of virus particles are produced, at
the expense of cellular integrity. Thus, the original notion of a
module as a unit that performs a task in support of the major
function of the system, i.e. in that case an infected tissue, organ or
organism, does not apply for viruses. On the contrary, viruses
subvert cellular (sub)modular processes for their purpose and their
buildup as a functional module.
Since the elements of a cellular module are recycled to perform
their function multiple times, the system must be recharged with
energy at one step of its cycle. ATPases or especially small GTPases
fulﬁl this function by binding and subsequently hydrolyzing the
respective nucleotidetriphosphate. Although small G-proteins play
pivotal roles for almost every cellularmodule, structural proteins with
nucleotidetriphosphate hydrolyzing activity (with the exception of
RNA- or DNA-polymerases) are apparently absent from virus
particles. As a consequence, input of energy into the functional cycle
of a virus occurs only during synthesis of proteins, which must
therefore be equipped with sufﬁcient conformational energy to
perform their various functions. Since most viral proteins or
submodules (again with the exception of polymerases) perform
their function only once, input of additional energy and thus the
integration of GTPases into a viral module are not required.
The absence of GTPases in viral modules might be also due to a
decisive difference in the tasks cellular and viral modules perform. In
vesicular transport, the hydrolyzing activity of small GTPases is used
to uncoat the vesicle in the cytosol. In contrast, uncoating of viruses
occurs after their entry into a freshly infected target cell. Assuming a
similar function, i.e. uncoating, for a hypothetical viral GTPase, high-
energy GTP would have to be integrated into virus particles. However,
the labile phosphodiester bonds of GTP would be prone to hydro-
lyzation in the harsh environmental conditions that the virus particles
can encounter during their passage from one organism to another.
Hence, virus uncoating –which ought to occur only after entering the
target cell –would be disturbed. To prevent this, viruses have adopted
other strategies than “own” GTPases to uncoat their genome in freshly
infected cells as will be described below.
3. Comparison of the functional cycle of transport vesicles and
enveloped viruses
3.1. Assembly
3.1.1. Principal requirements for budding of vesicles and enveloped virus
particles
In current textbooks, description of the replication cycle of a virus
usually begins with the binding of a virus particle to a receptor present
on a suitable target cell and ends with the release of virus particles
assembled from newly synthesized components. Here we start our
description of the replicative cycle of a virus with the assembly step to
facilitate its comparison with the functional cycle of a cellular
transport vesicle.
To create a functional vesicle or virus several elements of the
module must work together. Since transport is a vectorial process, the
membrane fromwhich the vesicle or virus is supposed to budmust be
deﬁned and cargo and components of the prospective vesicle must be
speciﬁcally transported to the budding site. The assembly of the
components often occurs via semistable submodular intermediates
each with a speciﬁc function. Certain elements must check the input
into the module, i.e. select the appropriate cargo and enrich it inside
the vesicle or virus. Besides the cargo other elements must beincorporated into the particle and exposed on its surface to mediate
recognition of and fusion with the correct target membrane. The
budding process itself needs an element which physically drives the
curvature of membranes to generate a bud. This is often achieved by
assembly and polymerization of cytosolic coat proteins on the
membrane. Other elements serve to select the site on the membrane
where the coat proteins should polymerize. After formation of a bud
the coat proteins (or other elements) must catalyze the ﬁssion of the
vesicle/virus from the donor membrane. Finally, the activity of all
elements must be orchestrated such that only functional vesicles, i.e.
those that contain all required elements and the cargo, are released
from the membrane [6,11]. In the case of viruses, selection of their
elements is less precise since the majority of released particles of
many virus families are non-infectious, i.e. they lack at least one of the
necessary components. This functional imperfection of virus budding
is overcome by the sheer abundance of particles released by an
infected cell (several thousands). For that purpose viruses can exploit
the resources of the infected cell, whereas a similar wasteful strategy
for vesicular transport would probably be detrimental for the cell's
physiology. The elements which perform the described functions will
now be discussed and compared for cellular transport vesicles and
enveloped viruses.
3.1.2. Assembly of virus particles from submodular structures
Most enveloped virus particles are assembled from at least two
submodular structures, the genome complexed to proteins (usually
called capsid) and the viral envelope containing spike glycoproteins
(often embedded in speciﬁc lipids), and additionally in most cases a
peripheral membrane protein (often designated “matrix protein”)
lining the inner leaﬂet of the membrane bilayer and representing the
coat. In the process of assembly of the virus particle, the molecular
interactions involved increasingly gain complexity and ultimately
lead to the formation of the viral module from submodular structures
as described below and depicted in Fig. 3 for inﬂuenza virus as an
example.
The segmented genome of inﬂuenza virus, which is arranged in
ribonucleoparticles (vRNPs), is assembled in the nucleus, while the
surface glycoproteins hemagglutinin (HA) and neuraminidase (NA)
are processed in the secretory pathway. vRNPs represent one
submodular structure with a clearly deﬁned inventory of elements
and a characteristic shape: for vRNPs to be formed, the viral RNA
segments ﬁrst form panhandle-like structures by base pairing, which
then interact with the nucleoprotein NP and the three subunits of the
viral polymerase, PA, PB1 and PB2 [12,13] (Fig. 3, bottom left). The
matrix protein M1 participates in transport of vRNPs out of the
nucleus, but also localizes peripherally to cellular membranes.
Meanwhile, the glycoproteins HA and NA ﬁrst form homooligomers
in the endoplasmic reticulum (ER), which are transported to the
plasma membrane and enriched in speciﬁc membrane subdomains
termedmembrane rafts (Fig. 3, right, see below). The cytoplasmic tails
of HA and NA are believed to bind to M1 via weak interactions, which
are ampliﬁed by oligomerization of M1 and which draw M1 to
membrane rafts. As a consequence of these molecular interactions,
cellular proteins are displaced causing the formation of the second
submodular structure, namely, viral envelopes preassembled at the
budding site. Finally, vRNPs bind to M1 causing assembly of the
complete virus module and its budding from the membrane [14,15].
Paramyxo- and rhabdoviruses follow the same scheme as outlined
for inﬂuenza viruses with formation of helical vRNPs in the cytosol or
nucleus, and assembly of the coat and packaging of the genome at the
plasma membrane [16,17]. In contrast, due to the large amount of
capsid-like particles present in the cytoplasm of infected cells, one
model for budding of SFV suggests that assembly of its capsid and
integration of the viral genome occur inside the cell. However, since
virus mutants defective in intracellular capsid formation can still form
functional particles, it is possible that the capsid-like particles in the
Fig. 3. Example of an input submodule: assembly of inﬂuenza virus. Molecular level:
molecular interactions (left; red arrows) between the viral RNA, the three polymerase
proteins (PA, PB1, PB2) and the structural protein NP build the viral ribonucleoprotein-
particle (vRNP). The glycoprotein HA (right) forms trimers, which associate with rafts
in the plasma membrane. The coat protein M1 associates with membranes, where it
binds weakly to the cytoplasmic tail of HA; these molecular interactions are illustrated
by green arrows. Submodular level: oligomerization of M1 strengthens the weak
interactions with HA and draws M1 to the viral budzone, preassembled viral envelopes.
This submodular entity contains also the second viral glycoprotein neuraminidase (NA)
and a few copies of the viral proton channel M2. Finally, the vRNPs bind to M1, a
complete virus particle buds from the membrane and is released. The hallmarks of
functional modules (grey lettering) are described in the text, Sections 3.1 and 3.2.
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assembly of infectious viruses occurs at the plasma membrane
[18,19]. Some submodular structures are not only transient intracel-
lular building blocks of virus particles, but stable functional units on
their own. An example are cells infected with hepatitis B virus (HBV),
which secrete subviral lipoprotein particles, viral envelopes devoid of
the capsid, at a 10,000fold higher concentration than virus particles,
probably as decoys for the immune system [20].
3.1.3. Deﬁnition of the budding site and transport of components to the
membrane
The coat lining themembrane of a vesicle or of a virus is assembled
from a cytosolic pool of monomers. In principle, assembly of the coat
could occur on any cellularmembrane, yet vesicles or viruses bud only
from speciﬁc membranes. Thus, the coat proteins must recognize
other elements (proteins or lipids) already present in the membrane
from which the vesicle or virus should bud.
The viral budding site is often deﬁned by speciﬁc localization of
viral glycoproteins at certain membranes or membrane microdo-
mains. In polarized epithelial cells viral glycoproteins are transported
either to the apical (HA of inﬂuenza virus) or basolateral membrane
(G of VSV) and as a consequence inﬂuenza virus buds only from apicalmembranes, whereas VSV buds from the basolateral membrane [15].
(For other viruses with a polarized budding phenotype, the coat
protein may be the determining factor.) Viruses which bud into
intracellular compartments (coronaviruses, ﬂaviviruses, HBV) contain
glycoproteins with intrinsic signals for their retention in the ER or
Golgi causing their accumulation in the membrane of the respective
organelle [21]. Many viral glycoproteins (HA and NA of inﬂuenza
virus, gp160 of HIV) which are transported to the plasma membrane
associate with membrane rafts [22], microdomains enriched in
cholesterol and glycolipids that are thought to serve as an platform
for assembly of virus particles by enriching viral proteins (and
excluding others), thereby facilitating speciﬁcally the protein–protein
interactions required for budding. As a consequence the envelope of
these virus particles closely resembles the lipid composition of
membrane rafts [23].
With the exception of coronaviruses (see below), the coat proteins
do not contain membrane-spanning regions and must thus associate
with membranes by other means. The Gag protein of HIV contains a
membrane binding signal composed of a myristoylated glycine and an
adjacent stretch of basic amino acids at its N-terminus. After
cotranslational myristoylation, the fatty acid is initially hidden inside
a hydrophobic cleft of the monomeric protein. Gag then binds via
electrostatic interactions to phosphatidylinositol-4,5-bisphosphate
(PtdIns(4,5)P2), a speciﬁc component of the plasma membrane.
Binding to the membrane facilitates multimerization of Gag and
exposes myristate, which now inserts into the lipid bilayer (myristyl
switch). The 2′, unsaturated acyl chain of PtdIns(4,5)P2 binds to the
now empty hydrophobic groove of Gag. The mutual exchange of a
fatty acid between PtdIns(4,5)P2 and myristoylated Gag causes a
stable association between both molecules [24]. An interesting
speculation suggests that Gag bound to PtdIns(4,5)P2 is then targeted
to membrane rafts, where it can associate with gp160 [25–27].
Binding to speciﬁc lipids has not been demonstrated so far for the
coat proteins of other viruses. The matrix proteins of ortho- and
paramyxoviruses (including inﬂuenza virus M1) have intrinsic
membrane binding properties, probably mediated by rather unspe-
ciﬁc electrostatic and hydrophobic interactions [28]. They accumulate
at various membranes, such as ER, Golgi and the plasma membrane
and theymight then be drawn to the budding site by interactions with
the cytoplasmic tails of viral spike proteins. The capsid protein of
hepatitis C has no intrinsic membrane targeting domain, but is
synthesized together with the glycoproteins as a polyprotein
precursor at the ER. Upon proteolytical cleavage, both the glycopro-
teins and the capsid protein remain associated with the ER membrane
ensuring colocalization of proteins prior to budding [21,29].
In the case of cellular transport vesicles, small G-proteins of the
ras-superfamily, such as Arf or the closely related Sar1, deﬁne the
budding site. They are recruited from the cytosol by binding to speciﬁc
transmembrane proteins localized in the donor compartment and are
activated by guanine-nucleotide exchange factors (GEFs). The GEF
causes exchange of GDP with GTP in the G-protein, leading to
exposure of its hydrophobic N-terminus, which is either myristoy-
lated or intrinsically hydrophobic, and insertion into the membrane.
This anchors the G-protein to speciﬁc membranes and serves as a
platform for assembly of the coat proteins [30]. The assembly site of
clathrin vesicles is additionally regulated by PtdIns(4,5)P2 and other
phosphatidylinositol lipids are likely to orchestrate assembly of
further cellular transport vesicles [31].
In summary, the budding site of viruses or vesicles is deﬁned by
elements having intrinsic signals for accumulation in certain
membranes or membrane domains, either transmembrane proteins
with intrinsic targeting signals and/or lipids present only in certain
membranes. The budding sites selected in this manner are recognized
by cytosolic coat proteins, which, however, might also have intrinsic
signals for binding to speciﬁc membranes. While the regulation by
PtdIns(4,5)P2 appears to be a common feature, the actual membrane
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GTPases which also provide the energy for the time-ordered and
repetitive functional cycles, while viruses have other proteins with
diverse membrane binding structures.
3.1.4. Input check: selection of cargo
Budding of viruses or vesicles containing a random selection of all
components present in the donor compartment would result in a very
inefﬁcient mechanism of transport. Thus, the input into the transport
module, either protein or the viral genome,must be checked to ensure
that the desired elements are enriched in the vesicle or virus.
Furthermore, both viruses and vesicles must incorporate other
elements into their membrane that facilitate targeting to and fusion
with the target membrane. As already mentioned above, the input
check of viruses tends to be less precise compared to vesicles since
many released virus particles are non-infectious. Likewise, the
formation of virus-like particles, containing a minimal number of
proteins, but lacking the genome, is possible (see below). However,
budding of vesicles is also not completely faultless, but missorted
cargo often contains a retrieval signal, such as KDEL or KKXX,
returning proteins that have left the compartment in which they
reside [32].
Checking the input is especially demanding in the case of viruses
with a positive-stranded RNA genome, which must select their
genome out of the many mRNA molecules of the cell. For example,
retroviral genomic RNA, which bears all hallmarks of cellular mRNA,
constitutes much less than 1% of an infected cell's cytoplasmic RNA
population. A component of the viral coat must therefore recognize
unique features in the viral genome. In retroviruses these packaging
signals are several hundred nucleotides long, sometimes discontinu-
ous stretches of RNA, which are absent in spliced or subgenomic viral
RNA molecules. The NC domain of the Gag-precursor binds to the
packaging signal via a zinc-binding motif and adjacent basic amino
acids. NC is inherently ﬂexible, and it is therefore possible that
different NC molecules bind to different regions of the packaging
signal, which is too long to be bound by a single NC molecule. As
retroviruses contain a diploid genome, speciﬁc base pairing between
loop sequences of individual RNA molecules ensures packaging of
dimers into virus particles, which is important for reverse transcrip-
tion in a freshly infected cell [33].
Another, even more demanding packaging problem appears with
viruses containing a segmented genome. For instance, newly formed
inﬂuenza virus particles must contain at least one copy of each of its
eight vRNPs to be infectious. A random packaging mechanism, in
which any eight RNA segments were incorporated into virus particles,
would yield a maximum of one infectious particle for every 400 (8!/
88) assembled. As several thousands of virus particles are released by
one infected cell, a random mechanism of packaging in principle
would not preclude production of viruses capable of infecting other
cells [33]. Nevertheless, recent cryo-electron microscopy (EM)
tomography has shown that each virus particle contains exactly
eight vRNPs, arranged as a speciﬁc pattern, seven in a circle
surrounding one in the center. Each vRNP visible in the tomogram
had a different length showing that eight different genes are present in
a virus particle [34]. These argues in favour of a highly selective
mechanism of genome packaging, but the individual packaging signals
present in each vRNP still need to be identiﬁed.
Besides the genome, budding virus particles must also incorporate
spike proteins to be infectious, but have to exclude most cellular
membrane proteins. The viral proteins contribute only 1% (or less) of
the surface proteins of the infected cell and yet the budded virus
particles contain just a few, if any, cellular proteins. Initial budding
models have proposed that very speciﬁc interactions between the
cytoplasmic tails of viral transmembrane proteins and the viral coat
ensure the integrity of virus particles [35], but this has been proven so
far only for budding of SFV as described below. Despite many efforts,binding sites for cytoplasmic tails of viral spike proteins have not been
identiﬁed in coat proteins of other viruses, suggesting that they are of
low afﬁnity [36]. It is also noteworthy in this regard that during a
mixed infection of a host cell with various unrelated viruses, so-called
pseudotypes can appear. These are virus particles that contain the
genome and the coat protein of one virus and the envelope proteins of
another. The largest numbers of examples of pseudotyping were
reported for vesicular stomatitis virus (VSV) and other viruses
containing a matrix protein [37]. Thus, viral coat proteins have the
remarkable ability to discriminate between cellular and viral
transmembrane proteins, although the latter do not possess sequence
homology in the region which may possibly interact with the coat. A
possible solution to this paradoxon would be a spatial separation of
viral from cellular proteins within the membrane. Rafts could perform
this function since many viral glycoproteins are present in detergent-
resistant-membranes, which are considered the biochemical correlate
of membrane rafts [38]. However, this correlation does not seem to
hold true in all cases [39–41] and other microdomains in the
membrane, besides rafts, may be responsible. Upon expression at
the plasma membrane, HA is neither randomly distributed, nor
accumulates only in domains with the size of a raft. Instead HA
molecules form irregular clusters on length scales from 40 nm up to
many micrometers. Thus, HA (and possibly other viral glycopoteins)
somehow accumulate in microdomains of the membrane or even
induce their formation, which leads to their separation from most
cellular proteins [22,42–44]. Alternatively, binding of the matrix
protein to the inner leaﬂet of the bilayer might modify the biophysical
properties of the membrane such that microdomains are formed that
are recognized mainly by viral glycoproteins.
In the case of cellular transport vesicles, the cargo proteins are
usually capable of binding directly to the element that drives the
budding reaction, i.e. the coat proteins. Transmembrane proteins
supposed to be retrieved from the Golgi to the ER contain a
cytoplasmic KKXX sequence that binds to a yet unknown component
of the COP I coat. The majority of cargo proteins that travel along the
exocytic pathway are concentrated in COP II vesicles prior to export
from the ER. Transmembrane proteins possessing di-acidic, di-basic or
short hydrophobic motifs in their tail bind to the sec24 subunit of the
COP II coat. The diversity of signals explains the ability of COP II to
package a wide variety of proteins. Endocytosis of surface receptors by
clathrin-coated vesicles requires adaptor proteins connecting the
receptor to the coat. The adaptors recognize sorting signals in the
cytoplasmic tail of receptors, such as critical tyrosines, di-leucines or
conjugated ubiquitin. If soluble components need to be transported,
transmembrane cargo receptors, such as the KDEL-receptor for
retrieval of lumenal proteins from the Golgi to the ER, are required,
which must also be incorporated into the vesicle. Likewise, certain
vesicular (v-) SNARE-proteins must be included to allow fusion of the
vesicle only with the anticipated acceptor membrane. SNAREs
involved in ER-to-Golgi transport bind to distinct sites of the Sec24
subunit of the COP II coat ensuring that vesicle budding and
subsequent fusion are mechanistically integrated [6,30].
In conclusion, the input into a virus particle or vesicle is checked by
speciﬁc interactions of coat components already present at the site of
assembly (often a speciﬁc membrane subdomain) and components of
the input. However, the exact nature of these interactions is,
especially for budding of virus particles, in most cases quite unclear.
Whatever the exact mechanism might be, the coat proteins must
somehow recognize that the binding sites are ﬁlled. The assembly
process is then switched off and a signal must be delivered that a
given preformed vesicle or virus particle is now ready for budding.
3.2. Budding
To release a vesicle or virus, some elements of the module must
bend the membrane, executing either a pushing or a pulling force on
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close (scission of the vesicle) and be released from the donor
membrane, reactions which may (or may not) require other elements
of the module.
3.2.1. Determinants of virus budding
Budding of a virus may either depend on inner coat proteins or
viral envelope glycoproteins, or both componentsmust work together
[21]. This can be experimentally determined by expression of
structural proteins of the respective virus in eukaryotic cells and
identiﬁcation of the minimal set of proteins required for release of
virus-like particles (VLPs), enveloped vesicles with the same density
and appearance as complete virus particles. For most retroviruses,
including HIV, paramyxo-, rhabdo- and ﬁloviruses, the expression of
coat proteins alone leads to the formation of VLPs, showing that
assembly of the coat protein at the membrane is the driving force for
virus budding. However, coexpression of viral glycoproteins often
enhances release of virus particles [16,17,45,46].
For inﬂuenza virus it was found recently that expression of the coat
protein M1 – which had previously been assumed to be the driving
force for inﬂuenza virus budding – is per se not sufﬁcient to produce
VLPs nor is it required for VLP formation. Instead, the major
determinant for VLP formation are the cytoplasmic tails of the
glycoproteins NA and especially HA [47].
In other viruses (HBV, corona- and ﬂavivirus), viral glycoproteins
alone catalyze budding of VLPs from a cell indicating that they can
execute a pulling force on the membrane. The M protein of
coronaviruses, which provides the driving force for budding, contains
only a short extraviral domain but three transmembrane segments.
Yet it self-assembles to higher-order complexes indicating that lateral
interactions occur within the membrane. The glycoproteins of
ﬂaviviruses do not project as visible spikes from the envelope, but
instead form a rigid shell which lies ﬂat on the envelope such that it
can execute force on the bilayer [20,48,49].
SFV requires interactions between glycoproteins and coat proteins
for budding. By combining atomic structures with cryo-EM it was
demonstrated that SFV contains two rigid protein coats or shells, both
with icosahedral symmetry. The capsid composed of the C-protein
lines the internal side of the membrane, whereas lateral interactions
between viral spikes form the outer shell. The spikes are composed of
E1/E2 heterodimers, which are grouped into 80 trimers. E1 is located
at the periphery of each trimer and mediates interactions between
spikes [50]. Each SFV-particle contains a ﬁxed set of viral proteins, i.e.
240 copies of the E1/E2 dimer and 240 copies of the capsid protein.
According to the enwrapping model of virus budding, the capsid
preassembles in the cytosol and when it approaches the membrane, it
interacts via a hydrophobic pocket in the C-protein with a Tyr-X-Leu
peptide present in the cytoplasmic tail of the E2 glycoprotein. If all of
its 240 binding sites are ﬁlled the capsid is completely enwrapped by
the E1/E2 containing envelope and as a consequence is released from
the membrane. Thus, sequential C–E2 interactions force the mem-
brane around the capsid. The alternative model suggests that
preassembled glycoprotein complexes cause binding of the C-protein
and facilitate capsid formation. Whatever the exact mechanismmight
be, a very precise shut-off mechanism for virus assembly must exist to
yield virus particles with a deﬁned molecular structure [19]. This
unique budding mechanism might explain why SFV does not use
membrane rafts for enrichment of viral proteins.
Most other enveloped viruses are not composed of a strictly
deﬁned number of proteins. As a consequence of having a variable
number of structural components, different virus strains (or even a
population of virus particles released from the same cell) exhibit
variations in their morphology. This is especially evident for inﬂuenza
viruses, which can form ﬁlamentous and spherical particles. Other
viruses, such as ﬁloviruses, are quite homogeneous in their morphol-
ogy, e.g. forming long ﬁlamentous particles each with the samediameter, but the length of virus particles can vary substantially
between individual virus particles.
Although there is in most cases some variability in the exact
composition of the viral module, the shut-off principles, which
determine when exactly a newly formed virus particle is completed,
remain to be elucidated. Shut-off is achieved by the interplay between
cargo and coat components. In the case of the bullet-shaped VSV the
vRNPs associate with the M protein at the plasma membrane of
infected cells, which leads to compaction of the vRNP into a skeleton, a
tightly coiled complex. Directly after enclosure of the nucleocapsid,
the virus buds are separated from the host cell. The size of the virus
particle depends on the length of the helical nucleocapsid, attachment
of foreign nucleic acid sequences to viral genes yields longer virus
particles. The concerted action of the submodular viral components
ensures that a functional virus is formed [16].
Morphogenesis of herpes viruses, which are among the most
complex virus particles, requires two budding events. Capsids
preformed in the nucleus are translocated to the cytoplasm by
budding at the inner nuclear membrane followed by fusion of the
primary envelope with the outer nuclear membrane. Final envelop-
ment, including the acquisition of dozens of tegument and envelope
proteins, occurs by budding into Golgi-derived vesicles. The two
budding events do not only differ in their intracellular location, but
also in the viral proteins involved. As an example, two membrane
proteins essential for budding at the inner nuclear membrane are
absent from mature virus particles. Furthermore, capsids direct
budding at the inner nuclear membrane, but do not trigger secondary
envelopment. Likewise, the glycoproteins which mediate membrane
fusion during cell entry of herpes viruses are not required for fusion of
the primary envelope with the outer nuclear membrane, indicating
that not only both budding processes, but also fusion events are
mechanistically different [51].
The exact way of how a virus particle is formed is, in most cases,
not well-characterized. On the whole, it can be stated that budding
mechanisms vary for different virus families, but that in most cases
the proteins which drive the budding reaction are engaged in lateral
interactions. They thereby pack into lattices to form a cage-like
construction at the outer surface of, within, or underneath the
membrane and thus resemble budding of cellular transport vesicles.
The budding mechanism of inﬂuenza virus may be unique since
intense lateral interactions between its spike proteins, the driving
force for budding, apparently do not occur. It was speculated that the
accumulation of viral glycoproteins in membrane rafts may induce
curvature of the membrane sufﬁcient for spontaneous vesicle
formation [47].
3.2.2. Virus budding by hijacking the cellular ESCRT module
However, assembly of viral proteins at the budding site is often not
sufﬁcient for release of virus particles. Budding may also require
cellular functions, which are recruited to the budding site by viral
proteins. This mechanism was ﬁrst found for the Gag protein of the
retrovirus HIV-1, where a so-called “late domain” (L-domain), which
affects late steps in virus budding, was identiﬁed. Viruses with a
mutation in this domain assemble and bud, but remain linked to the
infected cell by a thin bridge of continuous membrane bilayer, i.e.
scission of virus particles does not occur. Viral late domains are also
present in proteins of other viruses (but probably not in inﬂuenza
viruses) and consist of short amino acid sequences, such as P(S/T)AP
(Gag of HIV) or PPEY (M of ﬁloviruses), which are partially
interchangeable between viral proteins. Each L-domain binds to a
different cellular protein of the family of “class E VPS factors” (VPS =
vesicular protein sorting), which assemble to so-called ESCRT
complexes (endosomal sorting complexes required for transport). In
the cellular context ESCRT complexes are involved in sorting of
proteins into vesicles that bud into the lumen of endosomes thereby
forming multivesicular bodies (MVB). No detailed mechanistic
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proteins must mediate similar functions as coat proteins, e.g. sorting
of cargo proteins, induction of membrane curvature, and membrane
ﬁssion. However, in contrast to coated vesicles, which bud into the
cytosol, ESCRT-mediated budding occurs, like budding of viruses, out
of the cytosol. Thus, many enveloped viruses have hijacked a cellular
budding machinery (or parts thereof) for their own purpose making
use of a well-established and ﬁne-tuned cellular module. This
interplay leads to the formation of new submodules using viral and
cellular components that maintain modular regulation properties of
the original cellular module, but lead to formation of the viral module
[21,47,52].
The minimal set of elements required for budding and release of a
cellular transport vesicle has been experimentally deﬁned in vitro
with puriﬁed components for COP I and COP II vesicles. In both cases
addition of a small G-protein (Arf1 or Sar1) preloaded with GTP and
the subunits of the coat (coatomer plus cytoplasmic tails of cargo
receptors or sec24/24 and sec13/31) to liposomes leads to the
formation and release of vesicles. Thus, assembly of cytosolic coat
protein at membranes and their subsequent polymerization mediated
by the small G-protein drives the budding reaction, further elements
for scission of the vesicle are apparently not required [53,54]. In
contrast, release of clathrin-coated vesicles requires the large GTPase
dynamin, which forms a ring around the neck of the budding vesicle,
and GTP-hydrolysis provides the energy for scission [55]. Overall, the
budding of coated vesicles bears the closest similarities to those
viruses where assembly of cytosolic coat proteins on the surface of a
membrane and their subsequent polymerization are the driving force
for budding. This includes the retro-, rhabdo-, ﬁlo- and paramyx-
oviruses. The second principle of virus budding (by polymerization of
proteins within the membrane) is apparently also used by cells.
Endocytosis of caveolae is probably executed by polymerisation of
caveolin, a protein that has two cytoplasmic domains and inserts into
membranes with a hairpin conﬁguration. Binding of caveolin to
cholesterol, a raft-lipid, is also required for endocytosis, emphasising
that not only proteins, but also lipids are key players in budding of
vesicles and viruses [56].
In summary, virus assembly shares features with the assembly of
coated transport vesicles. Both require the bringing together of many
components – transmembrane proteins, coat proteins and the cargo –
at speciﬁc sites of cellular membranes so that an ordered series of
speciﬁc interactions leads to recognition and assembly. Often the
components to be assembled are concentrated and segregated from
the other cellular components so that the appropriate interactions
become more likely. Most of the required interactions are probably
rather weak since it must be easy to disassemble the module after it
has fulﬁlled its function. Recognition of weak signals is enhanced by
cooperativity, e.g. oligomerisation of coat proteins, and assembly of
the components in a two-dimensional milieu, e.g. at a membrane or
even at a speciﬁc microdomain of a membrane. This enhances the
effect of the individual recognition steps so that a weak preference for
interaction between two components becomes ampliﬁed by cooper-
ation among many. Consequently, assembly in two dimensions must
use a hierarchy of sorting steps and mechanisms for regulation and
control that allow selection of the correct components and exclusion
of incorrect ones.
3.3. Maturation of viruses and uncoating of vesicles
We have so far discussed assembly and budding of the viral
module, a process in which the biological activities of the viral
submodules and elements are switched off rather than activated as in
the case of cellular functional modules of the cell. For instance, all
enzymatic activities of the viral genome of inﬂuenza viruses are
inhibited by assembly of vRNPs into a compact structure and their
subsequent transport out of the nucleus. A key role in this process isplayed by the viral M1 protein. M1 is transported into the nucleus,
where it binds to the vRNPs and mediates (in collaboration with the
viral nonstructural protein NS2/NEP) their export through the nuclear
pore to the budding site. The transcription activity of the vRNPs is not
resumed before M1 is released from vRNPs in the low-pH environ-
ment of the target cell's endosome (see below). Thus, binding of M1 to
vRNPs and subsequent release can be regarded as a molecular switch
regulating the activity of the inﬂuenza virus genome [14,57].
Likewise, upon budding of inﬂuenza virus particles, the lipids of
the viral envelope become immobile and, as a consequence, the lateral
mobility of the viral glycoproteins HA and NA in the membrane is
restricted. The formation of ordered lipid domains in the membrane
requires enrichment of cholesterol and of lipids containing unsatu-
rated fatty acids in budding virus particles, which is probably
mediated by S-acylation of the cytoplasmic tail of HA [58]. The
saturated fatty acids may collect other saturated-chain lipids and
cholesterol when HA is concentrated in the plasma membrane before
budding. Since ordered lipid domains are especially prominent at
ambient temperature they are thought to stabilize virus particles
against environmental conditions, which is especially critical for
viruses spread by airborne transmission [59]. Thus, unlike vesicles,
which are processed after release from their donor compartment, the
elements of a virus generally remain in an inactive, “frozen” state after
virus release to protect the virus genome against harmful environ-
mental conditions. The virus then needs to be “reanimated” upon
encounter of an infectable cell.
Nevertheless, freshly budded viruses are often exposed to simple
maturation steps, carried out by cellular or viral enzymes, which are
required to allow their release from the infected cell and to prepare
the particle for subsequent steps of docking at and fusion with their
target membrane. Virus surface component mediating attachment to
target cell must be prevented from binding with the virus receptors
on the cell from which the virus is exiting. This can be achieved by
virus-induced down-regulation of the virus receptor on the cell
surface, by limiting the budding to a distinct part of the cell surface or
by an enzymatic reaction. The latter is found in the case of inﬂuenza
virus, where viral HA interacts with cellular surface glycoproteins
containing sialic acid. This step is required for binding of viral particles
to a cell to be infected, but disadvantageous when freshly assembled
virus particles are to be released from an infected cell. The second viral
glycoprotein NA cleaves sialic acid from every cellular glycoprotein
and glycolipid it encounters during its transit through the exocytic
pathway to the plasma membrane and thus destroys the cellular
receptor on the infected cell. Likewise, NA cleaves sialic acid also from
viral HA to avoid aggregation of virus particles and loss of infectivity
[60].
Maturation of viruses during or after budding often involves
proteolytic cleavage of structural proteins, which prepares the virus
for subsequent fusion or uncoating steps. The coat protein of HIV is
synthesized largely as a Gag-precursor containing the matrix protein
(MA), the capsid protein (CA), the nucleocapsid protein (NC) and the
p6 protein (containing the recognition motif for elements of the
cellular ESCRT-complex, see above) as one large polypeptide chain.
Smaller amounts (5%) of a Gag–Pol fusion protein containing also a
protease (PR) and the polymerase are also made. After its synthesis
the polyprotein binds to the plasma membrane and polymerizes,
which initiates budding of virus particles as described above. The low
autoproteolytic activity of the Gag-precursor cleaves the polyprotein
into the mentioned subunits. This releases free protease, which is
more potent and rapidly attacks further Gag-precursors causing the
release of more protease. Thus, a positive feedback mechanism exists
until every polyprotein is cleaved. Upon cleavage, the spherical Gag
shell typical of the immature particle undergoes structural rearrange-
ment to form a morphologically distinct mature particle, which can
even be recognized in EM-pictures. Whereas immature particles have
a disorganised central core, the matrix protein lines the inner side of
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cone-shaped core containing the genome complexed to the nucleo-
capsid protein and the polymerase. Proteolytic cleavage of the Gag-
precursor is not required for budding, but prepares the virus for the
subsequent uncoating of its genetic material in a freshly infected cell.
This process must be regulated such that the initial proteolytic attack
does not occur in the cytoplasm, but only during or shortly after the
budding of the virus particle [26,61].
Another drastic maturation step occurs in ﬂaviviruses after their
budding, affecting the external protein shell composed of the E and
preM-glycoproteins. Members of this virus family bud from the
cytosol into the lumen of the ER and are subsequently secreted by the
cell. During passage of virus particles through the trans-Golgi-
network (TGN), preM is cleaved at a stretch of basic amino acids by
a cellular protease from the furin-family. This changes the arrange-
ment of the protein shell, the 60 trimers composed of pre M–E
heterodimers are restructured to form 90 homodimers, which is an
essential prerequiste to allow the E-protein to perform its fusion
activity in the target cell [49].
Proteolytic cleavage of glycoproteins by trypsin-like proteases at
either monobasic or polybasic sites occurs for many enveloped
viruses, such as myxo- and alphaviruses, affecting either a protein in
a complex with a fusion protein or the fusion protein itself. Proteolytic
cleavage is an essential step of virus maturation since it primes the
fusion protein for subsequent activation at the cell the virus is about to
infect. Proteins with a polybasic stretch of amino acids at the cleavage
site are proteolyzed inside every cell by a ubiquitous protease of the
furin-family present in the TGN. Fusion proteins with a monobasic
cleavage site are not recognized by this protease; therefore, they have
to be cleaved by an extracellular protease, which usually takes place in
the organism to be infected [62]. The fusion proteins of other viruses
(e.g. SARS corona virus, Ebola) are cleaved after uptake into the
endosome by proteases of the cathepsin family [63,64].
In the case of cellular transport vesicles, the function of viral fusion
proteins is fulﬁlled by SNARE-proteins, C-tail anchored transmem-
brane proteins with their N-terminal domain facing the cytosol (see
below). To expose the v-SNAREs, transport vesicles must lose their
coat. Small G-proteins present in the vesicle, Arf or Sar, hydrolyze GTP,
which causes retraction of their hydrophobic N-termini from the
membrane and detachment of the G-proteins from the vesicle
membrane. This destablilizes the coat, which is disassembled, and
its constituents are released into the cytosol, where they serve as a
pool for the formation of new vesicles (recycling). It is still unclear
how the GTPase activity is regulated, but it must contain a timing
scheme which prevents disassembly of the coat before the vesicle has
completely budded from the membrane.
3.4. Tethering and docking to the target membrane
The biologically “frozen” state of the virus after budding is
overcome when the virus binds to a suitable receptor on the surface
of a target cell. Often only a few hydrogen bonds are involved in
binding [65], but the reaction triggers a cascade of events leading to
membrane fusion, disassembly of virus particles, cargo release,
disassembly of its submodules containing the nucleic acids, and
ﬁnally to transcription and replication of the viral genome. These
events must be temporally coordinated for successful infection of
cells: for instance, the infectivity of the virus would be irreversibly
destroyed if the fusion activity were triggered prior to virus binding to
the target cell. Thus, recognition of the cellular receptor by the
viral glycoprotein is a modular switch that activates the further
processing events of the module, which are schematically depicted in
Fig. 4.
The presence of a suitable receptor on the cell surface is recognized
by a viral glycoprotein and is one of the factors that determine the
type of cell a certain virus can infect. Some receptors are present onmany cell types, such as glycoproteins and glycolipids containing
terminal N-acetyl neuraminic acid (sialic acid) recognized by
inﬂuenza virus HA (see Fig. 4, green box, for the molecular details of
this interaction). However, avian and human viruses have a different
preference for the type of linkage that attaches the sialic acid moiety
to the penultimate sugar of the carbohydate chain, galactose. Human
viruses preferentially recognize an α2,6 linkage, whereas avian
viruses require an α2,3 bond. Since the matching receptors are
distributed correspondingly in human and avian epithelial cells, the
type of receptor represents a species barrier an avian virus, e.g. the
H5N1 virus, has to overcome to become a human pathogen [65,66].
Other viruses recognize even more speciﬁc receptors on the target
cell, such as the nicotinic acetylcholine receptor present on moto-
neurons, which is used by the G-protein of rabies virus, or CD4 present
on T-helper cells, which is recognized by gp160 of HIV. Successful
infection of T-helper cells by HIV requires a second component, a
member of the chemokine receptor family. Thus, HIV uses a “two step
mode” of cell binding; other viruses, e.g. herpes viruses, also require
two types of receptors to which they bind with low and high afﬁnity,
respectively. This two step mode of binding thus resembles reversible
tethering and irreversible docking of cellular vesicles. Binding to the
ﬁrst receptor allows viruses to sample whether the second, high-
afﬁnity receptor is present— if no receptor is found virus particles are
discharged. Release of unproductively bound viruses may also be
exerted by a receptor-destroying activity present in one of the viral
glycoproteins. An example is the neuraminidase of inﬂuenza and
paramyxoviruses, which removes virus particles from their receptor if
subsequent steps of virus entry do not follow. This is especially
important during virus invasion into an organism since virus particles
have to make their way through the sialic acid containing mucus
present in the airways until they encounter a susceptible cell. Thus,
the input signal for the switch that activates the virus might be turned
off if subsequent steps of virus entry do not occur [67,68].
Cellular transport vesicles also use a two step binding mode to
attach to their acceptor compartment. Each membranous compart-
ment is equipped with speciﬁc tethering complexes, either large
multisubunit particles, such as TRAPP or the exocyst, or long putative
coiled-coil proteins, such as p115. Tethering complexes interact with
appropriate transport vesicles, where they activate a member of the
family of rab-proteins, small GTPases of the ras-superfamily. Activated
rab then interacts with its downstream effectors, which triggers a
cascade of events that prime the subsequently acting SNARE-proteins
to fulﬁl their function, docking and fusion [69,70].
Each type of vesicle is equipped with a speciﬁc v-SNARE-protein
recognizing only cognate t-SNAREs (“t” standing for “target”) present
in the acceptor compartment with which the vesicle is destined to
fuse as described below. Thus, tethers, rabs and SNAREs collaborate in
a sequential series of events to ensure that cellular membranes fuse at
the correct time and place. However, it does not universally hold true
that each module or submodule has its unique protein inventory. For
example, the TRAPP subunit Bet3, which we know to be associated to
the submodular function of vesicle tethering, is also found to interact
with subunits of the COP II vesicle coat. Since the coat is removed from
the vesicle before tethering, this means that Bet3 must be associated
to more than one submodular function [8].
3.5. Membrane fusion catalyzed by SNAREs and viral fusion proteins
In order to release the cargo (protein or viral genome), the
membrane envelope of the vesicle or virus has to fuse with the target
membrane, which results in a continuous connection between the
vesicle/virus lumen and the target compartment.
There are two pathways into the cell's cytoplasm used by
enveloped viruses, each associated with a different activation mode
of the fusion activity. Some viruses, such as retroviruses and
paramyxoviruses, fuse directly with the plasma membrane of the
Fig. 4. Example of an output submodule: cell entry and disassembly of inﬂuenza virus. Submodular level: (A) The virus particle docks to a receptor on the target cell, thus causing
endocytosis of the receptor with bound particle. Molecular details of receptor binding, framed in the green box, are shown in the lower part of the ﬁgure. (B) The low pH in the
endosome (arising from ATPases in the endosomal membrane) activates HA, which catalyzes fusion of viral and endosomal membrane (red box, see the blow up at the bottom). The
viral membrane contains the proton channel M2 which acidiﬁes the interior of the virus particle, causing displacement of M1 from vRNPs (switch). vRNPs are released through the
fusion pore into the cytoplasm of the cell. (C) In the nucleus, the compact structure of the vRNPs is partially disassembled allowing synthesis of mRNA and vRNA. The hallmarks of
functional modules (grey lettering) are described in the text, Sections 3.4–3.6. Molecular level: green box: interaction of HA with a sialic acid containing receptor. The peptide-
backbone of HA (blue) with the amino acids (cyan) involved in recognition of the substrate sialic acid-galactose-N-acetyl-glucosamine (orange). Figure modiﬁed with Pymol from
pdb ﬁle 2WR7, [84]. Red box: conformational changes in HA leading to fusion of the viral with the endosomal membrane. The fusion peptide (red) becomes exposed on the
molecule's surface after acidiﬁcation (a) and inserts into the cellular membrane (b). A second conformational change then bends HA (c), which leads to hemifusion with exchange of
lipids (d) and opening of a fusion pore (e). For clarity, the receptor-binding HA1 subunit (grey) is omitted in b to e. Picture modiﬁed from Ref. [85].
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viral fusion protein might be identical with (retroviruses) or different
from (paramyxoviruses) the receptor-binding protein. In the latter
case a signal generated by binding to the cellular receptor must be
transmitted to the fusion protein. Other viruses, such as inﬂuenza, are
taken up by endocytic vesicles, which they use as a ferry for their
transport from the periphery of the cell to a perinuclear location.
However, since endosomes ultimately fuse with lysosomes, the virus
has to leave the compartment early enough to avoid degradation by
hydrolytic enzymes. The increasingly acidic pH generated by amembrane proton pump V-ATPase in the endosome triggers a
conformational change in HA that executes fusion of viral and
endosomal membranes thereby allowing access of vRNPs to the
cytoplasm [67,68,71,72]. Enveloped viruses often exhibit ﬂexibility in
cell entry, being able to use different pathways. Inﬂuenza viruses uses
both clathrin-dependent and -independent endocytosis for uptake
and HIV, which can fuse with the plasma membrane, can also utilize
endocytotic vesicles for cell entry [73,74].
Elucidation of the X-ray structure of the hemagglutinin at neutral
and mildly acidic pH, which are equivalent to the HA structure before
517B. Thaa et al. / Biochimica et Biophysica Acta 1803 (2010) 507–519and after membrane fusion, has led to amodel on how conformational
changes of HA execute membrane fusion. An internal hydrophobic
segment (fusion peptide) at the N-terminus of the subunit HA2, which
is buried inside the trimeric structure at neutral pH, becomes exposed
on the molecule's surface after acidiﬁcation. It is thought to insert into
the cellular membrane allowing the molecule to exert force on the
bilayer. A second conformational change then bends HA thereby
drawing the fusion peptide towards the transmembrane region. The
second conformational change requires two so-called “heptad
repeats”, amphipathic helices in the vicinity of the fusion peptide
and the transmembrane region, which interact to form a stable coiled-
coil domain. The two conformational changes resemble the opening
and subsequent closing of one blade of a pocket knife. This leads to a
close apposition of viral and endosomal membranes, hemifusion with
exchange of lipids, opening of a fusion pore and eventually complete
merger of both lipid bilayers [65]. (See Fig. 4, red box, for detailed
series of events.) Many other viral fusion proteins, e.g. the F-protein of
paramyxoviruses and gp160 of HIV, have a similar helical coiled-coil
structure as inﬂuenza virus HA after fusion suggesting that they cause
membrane fusion by a similar mechanism. Other viral fusion proteins
do not exhibit a helical coiled-coil structure after fusion, but the basic
principle of their fusion mechanism is the same: exposure of a fusion
peptide that is hidden in the unactivated state, its insertion into the
cellular membrane and a second conformational change, which pulls
on and ﬁnally fuses the membranes [75]. Membrane fusion is not an
achievement of fusion proteins alone, since speciﬁc lipids must be
present at the fusion site to allow negative and positive curvature of
the bilayer required at the different steps of membrane merger [76].
Cellular SNAREs do not contain initially hidden fusion peptides,
but catalyze membrane fusion by the formation of a complex
composed of the v-SNARE and several t-SNAREs anchored in the
target membrane. This SNARE-complex forms a coiled-coil structure
similar to that of HA after fusion. The function of the viral fusion
peptide, i.e. insertion into the target membrane to execute force, is
carried out by the transmembrane region of the t-SNAREs, and the
formation of the SNARE-complex tightly connects and ﬁnally fuses
both membranes (zippering-mechanism). Thus, although viral and
cellular fusion proteins have no homology in their primary structure,
the mechanism how they execute membrane fusion is surprisingly
similar [7,77]. However, SNARE-proteins are recycled for further
functional cycles after the SNARE-complex has been disassembled by
the ATPase NSF [7], whereas viral fusion proteins are dispensable after
successful delivery of the viral genome into the cytoplasm.
3.6. Uncoating of the virus and cargo release
Viruses must be assembled in such a way that this assembly can be
reversed later on in subsequent infections. Thus, a control mechanism,
i.e. a switch must exist to shift the equilibrium of metastable
interactions to assembly in the cell the virus is about to leave and to
disassembly in a newly infected cell. During inﬂuenza virus infection
this is achieved by chemically different environments upon assembly
and disassembly. Assembly of inﬂuenza virus occurs at the neutral pH
of the cytoplasm, whereas disassembly is accomplished through the
low pH which the virus encounters in the endosome. The protons in
the endosome trigger an irreversible conformational change in the
hemagglutinin, which thereby gets activated to catalyze fusion of viral
and endosomal membranes (see above). At the same time the interior
of virus particles is acidiﬁed through the proton-channel activity of
the third viral envelope protein, M2 [78]. The protons induce the
dissociation of M1 from vRNPs, which are then released through the
fusion pore into the cytosol [57]. Thus, upon infection, the fragmen-
tation of the viral module into submodules and single components is
achieved via spatial sequestration and chemical speciﬁcity (see Fig. 4).
Due to intrinsic targeting signals, vRNPs are transported to the
nucleus, where their compact structure is opened and partiallydisassembled. From the vRNA the three polymerase subunits
synthesize messenger RNA for ampliﬁcation of viral elements and
(via a cRNA intermediate) new genomic vRNA. The switch from
mRNA to vRNA synthesis is regulated by the number of NP-molecules,
which bind to elongating RNA-strands thereby allowing the poly-
merase to make a vRNA copy. Thus, in the absence of NP, as it occurs
when the viral genome has just entered the cell, mRNAs (and
subsequently viral proteins) are made, whereas later in infection,
when NP (and other viral proteins) are abundant, a switch to genome
replication occurs. The submodular activity of transcription and
replication is ﬁnally switched off by export of vRNPs from the nucleus,
which is regulated by binding to M1 and which requires also the
nonstructural protein NS2/NEP [13].
Alphaviruses, such as SFV, use an entirely different strategy
involving other cellular modules. The 60S subunit of the ribosome
has high-afﬁnity binding sites for the viral capsid protein. The
interaction with the ribosome disassembles incoming capsids thereby
liberating the viral RNA, which can be instantly used for the synthesis
of nonstructural proteins. When synthesis of structural protein starts
later in infection, abundantly expressed capsid proteins saturate the
binding site on the ribosomal subunits, which thus can no longer
interfere with assembly of progeny capsids. Alternatively, the
structure of freshly assembled capsids may be different from
incoming capsids such that only the latter can associate with
ribosomes [19].
Cellular transport vesicles also use a difference in the pH of the
donor and acceptor compartment to discharge their cargo, similarly to
the processes outlined above for inﬂuenza virus. Endocytic vesicles
contain a proton pump which acidiﬁes their lumen after internaliza-
tion. Upon drop in pH the receptors dissociate from their ligands and
are recycled back to the cell surface. Likewise, the KDEL-receptor
binds its ligand optimally at acidic pH, which suggests that pH
differences between the Golgi and ER might control the association
and dissociation of the KDEL ligands [30].
4. A modular perspective of pharmacological intervention
Most currently available antiviral drugs target individual viral
enzymes, such as the neuraminidase of inﬂuenza virus, the protease
and transcriptase of HIV and thymidine-kinases of herpes viruses
[60,79]. As cells have enzymes performing similar functions these
drugs often interact which their cellular counterpart leading to
unwanted side effects. Most importantly, a single point-mutation in
its target often prevents binding of these drugs. Since the high
mutation rate observed for all viral genomes supplies such mutations
with a high frequency, viruses which avoid the inhibitory action of
these drugs emerge rapidly.
The modular character of viral assembly makes it a multistep
process of increasing hierarchy and complexity. Based on this
property, new targets for pharmacological intervention may arise,
which do not inhibit enzymatic activities, but block another function
of the viral module, for example cell entry. A step in this direction is
the drug Fuzeon®, which was licensed in 2003 as a new class of
antiretroviral drugs for HIV therapy. Fuzeon, a peptide that corre-
sponds in its sequence to one of the mentioned heptad repeats of the
fusion protein gp41, prevents the second conformational change of
the glycoprotein, which executes membrane fusion. The efﬁciency of
such drugs can even be increased by linking them to cholesterol,
which targets the molecule to raft domains where HIV fusion occurs
[80]. However, the application of Fuzeon has led to the appearance of
resistant virus strains, since the binding site of the peptide in the other
heptad repeat region can change without affecting the fusion activity
of the protein [81].
The overall function of a functional module always relies on the
ﬁne-tuned interplay between different submodules. The idea would
therefore be to interfere with this interplay, for example by inhibiting
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this respect is a study describing a peptide that binds to the capsid-
domain of gag of HIV thereby inhibiting assembly of immature and
mature capsids in the test tube [24,82]. Such drugs might be even
better if they block the interaction surface between two different
components of a virus particle, for example between different
proteins of a viral coat or between spike proteins and coat proteins.
The use of such therapeuticals might be less prone to the formation of
resistant virus strains, since this would require several mutations on
different submodules or molecular components, which must simul-
taneously occur to confer drug resistance. This has not been
sufﬁciently exploited so far in the search for antiviral drugs and
offers a new ﬁeld of intervention.
Likewise, a better understanding of the interplay between viral
and cellular modules might also lead to the development of novel
antiviral drugs. Viruses domake use of cellularmodules, such as signal
transduction cascades (activated by binding of viruses to a receptor on
the cell surface), ribosomes for protein synthesis and vesicles for
transport of newly synthesized glycoproteins to the viral assembly
site. Inhibition of such non-redundant cellular modules would block
replication of a virus, but would obviously also disturb vital functions
of the cell. An exception might be the various vesicular transport
pathways, such as phagocytosis, macropinocytosis, clathrin-, caveolae
or raft-mediated endocytosis, which a cell uses to internalize
extracellular compounds [67,68]. Most, if not all, viruses hijack one
of these pathways to gain entry into the host cell. The exact
composition of the endocytic modules and submodules is currently
an emerging area of research. Protein kinases, which selectively
control one of several different entry pathways, have been identiﬁed
as promising drug targets. The strategy is based on the assumption
that cells are robust enough to allow temporal inactivation of one of
their endocytic pathways, whereas simple viruses are not prepared to
use backup strategies if their obligatory entry pathway is blocked.
Furthermore, since genetically unrelated viruses might use the same
entry pathway, it is even imaginable that broad-spectrum antivirals
might be developed [83]. Thus, the search for such drugs might be
very promising, but requires a better understanding of the modular
features of the viral life cycle and the ﬁne-tuned interplay between
viral and cellular function.5. Conclusion
In spite of distinctive differences, common principles govern
vesicular and viral function. The similarity does not arise from the
same or similar elements which are used — there is not even a high
degree of sequence homology between any of the analogous elements
that constitute the vesicular and viral modules. The similarity rather
arises from the basic composition and functionality of the underlying
structures and their dynamics. For example, it is a decisive property of
biological membranes, indispensable to life, that they allow the
selective and controlled passage of cargo. To transit the membranes
that sequester intracellular compartments from one another, life has
invented proteins to induce membrane bending, using the ﬂuidity of
the lipid bilayer. The virus mimics this ability by employing virus
fusion proteins (which replace the vesicular SNAREs). The “fraud”
which viruses commit is not on the level of the same or similar
molecular inventory but on the level of submodular function.We have
seen that this extends to the essential properties and hallmarks of
cellular modules: Functional input–output cycles, spatial sequestra-
tion of elements, ampliﬁcation of signals and negative feedback occur
also during the replicative cycle of an enveloped virus. The occurrence
of the same schemes in two entirely different domains of life may
imply that these submodular functions are indeed a critical level of
biological organisation [1], reﬂecting general biochemical and
biophysical design principles.Acknowledgements
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Arf: ADP-ribosylation factor, member of a family of small G-proteins (GTPases) involved
in assembly and budding of COP I and clathrin vesicles.
Clathrin: Coat protein mediating the formation of endocytotic vesicles at the plasma
membrane and at the trans-Golgi network.
COP I: Coat protein complex I, mediating the formation of vesicles for retrograde
transport from the cis-Golgi to the ER and probably through the Golgi.
COP II: Coat protein complex II, protein complex mediating the formation of vesicles for
anterograde vesicle transport from the ER to the Golgi.
ESCRT: Endosomal sorting complexes required for transport, protein complexes
involved in the budding of vesicles into endosomes (formation of multivesicular
bodies) and the budding of some viruses, e.g. HIV.
Gag: Group-speciﬁc antigen, precursor protein of (among others) HIV matrix protein
(MA, N-terminally myristoylated), capsid and nucleocapsid proteins (CA and NC,
respectively), cleaved into its subunits by the viral protease.
gp160: 160 kDa glycoprotein, precursor of HIV surface glycoproteins gp120 (mediating
binding of the virus to its cell surface receptor CD4) and gp41 (fusion with the cell
membrane of the target cell).
HA:Hemagglutinin, surface glycoprotein of inﬂuenza virusmediating attachment to the
target cell (binding to sialic acid) and fusion with the target membrane.
HIV: Human immunodeﬁciency virus, a retrovirus (positive-stranded RNA genome
transcribed into DNA upon infection). Surface glycoprotein: gp160; coat protein: Gag.
M1:Matrix protein of inﬂuenza virus, coat protein lining the inner surface of the virion
and organiser of virus assembly.
NA: Neuraminidase, surface glycoprotein of inﬂuenza virus, cleaves sialic acid from
glycoproteins and thus mediates virus release.
PtdIns(4,5)P2: Phosphatidylinositol-4,5-bisphosphate, a lipid of the plasma membrane
serving as a substrate for the formation of secondmessengers (signal transduction)
and docking site for proteins.
Sar1: Small G-protein (GTPase) involved in the assembly and budding of COP II vesicles.
SFV: Semliki Forest virus, an alphavirus with single-stranded positive-sense RNA genome in
an icosahedral capsid and 80 trimers of E1/E2 embedded in the virus envelope.
SNARE: Soluble N-ethylmaleimide sensitive factor attachment protein receptor, coiled-
coil SNARE-complex between a v-SNARE on the vesicle and t-SNAREs on the target
membrane mediates vesicle attachment and membrane fusion.
VLP: Virus-like particle, cargoless non-infectious vesicle with similar size and density as
a virus, produced by cells upon expression of the viral components necessary for
budding.
vRNP: Viral ribonucleoprotein-particle, complex of viral RNA, nucleoprotein (NP) and
polymerases.
VSV: Vesicular stomatitis virus, a rhabdovirus with single-stranded negative-sense RNA
genome, surface glycoprotein G, coat/matrix protein M, and helical nucleocapsid.
